BTCC
/
BTCC Square
/
Global Cryptocurrency
/
Johnson & Johnson Q2 Earnings Surpass Expectations, Lifts Full-Year Guidance
Johnson & Johnson Q2 Earnings Surpass Expectations, Lifts Full-Year Guidance
18
3
BTCCSquare news:
Johnson & Johnson delivered a robust second-quarter performance, with adjusted earnings of $2.77 per share eclipsing the $2.66 consensus. Revenue climbed 5.8% year-over-year to $23.74 billion, fueled by strength in both MedTech and Innovative Medicine segments. The healthcare giant raised its full-year revenue outlook to $93.2–$93.6 billion and EPS guidance to $10.80–$10.90.
Pipeline advancements in oncology and neurology therapies position J&J for sustained growth. Shares gained 2.35% in premarket trading, extending the stock's 7% year-to-date rally. The results underscore the company's ability to outperform despite macroeconomic headwinds.
By:
Previous
Russia Advances Digital Ruble Rollout with New Legislation
Next
Toncoin (TON) Powers Casino.TG as First Native Telegram Casino with Crypto Integration
